Liquid pharmaceutical formulations of palonosetron
DC CAFCFirst Claim
Patent Images
1. A pharmaceutically stable isotonic intravenous solution of palonosetron hydrochloride for reducing emesis or reducing the likelihood of emesis comprisinga) from about 0.03 mg/mL to about 0.2 mg/mL palonosetron as palonosetron hydrochloride,b) a sterile pharmaceutically acceptable aqueous carrier comprising mannitol as a tonicity agent, at a pH of from 4.0 to 6.0, andc) EDTA in an amount of from 0.005 to 1.0 mg/mL.
7 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
38 Citations
6 Claims
-
1. A pharmaceutically stable isotonic intravenous solution of palonosetron hydrochloride for reducing emesis or reducing the likelihood of emesis comprising
a) from about 0.03 mg/mL to about 0.2 mg/mL palonosetron as palonosetron hydrochloride, b) a sterile pharmaceutically acceptable aqueous carrier comprising mannitol as a tonicity agent, at a pH of from 4.0 to 6.0, and c) EDTA in an amount of from 0.005 to 1.0 mg/mL.
Specification